Press releases from Recursion Pharmaceuticals

Recursion Unveils First Neuroscience Phenomap in $30 Million Collaboration with Roche and Genentech

Aug 6, 2024, 08:22 PM

Recursion Pharmaceuticals has announced the creation of the first neuroscience phenomap, called 'Neuromap,' under its collaboration with Roche and Genentech. The project, which received $30 million in funding, involved producing over one trillion hiPSC-derived neuronal cells, one of the largest datasets of its kind. This achievement marks a significant milestone in neuroscience, leveraging new genetic perturbation techniques to advance neuro-target discoveries. The Recursion team has accomplished many world firsts in this endeavor.